ErbB2-positive tumour cells that also expressed MUC1 were specifically targeted, stimulating an ErbB2-dependent immune activation with increased production of IFN-γ that synergistically promoted a cytotoxic response, although IL-2 secretion was relatively low compared to control CAR-T cells [95]. Here, ERBB2 is linked to neoplasm.